One of FCF’s partners, the Cancer Research Institute, is holding an event to discuss and explore natural killer (NK) cells, specialized immune cells that can recognize and destroy threats, including cancer. Due to their unique capabilities, they have great potential in cancer immunotherapy, with multiple NK cell-based approaches already being evaluated in clinical trials.
In this webinar, CRI will explore how NK cells work and how they may be applied against cancer. The webinar will feature renowned NK cell expert Lewis L. Lanier, Ph.D., and Oscar A. Aguilar, Ph.D., a Cancer Research Institute (CRI) fellow in Dr. Lanier’s lab at the University of California, San Francisco (UCSF).
Click here for more information and to register.